SEHCAT
Identification of Sehcat
| No description |
Google image searchProduct monograph
Active ingredient
tauroselcholic acid (75se), 370 KBq
DIN: 02329050
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Schedule C
Company: GE HEALTHCARE CANADA INC
Date: 26-FEB-2019
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09D — HEPATIC AND RETICULO ENDOTHELIAL SYSTEM (ATC, ATC/DDD)
- V09DX — Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals (ATC, ATC/DDD)
- V09DX01 — SELENIUM 75 SE TAUROSELCHOLIC ACID (ATC/DDD)
